glp-1 receptor agonists are contraindicated in Agonists: Mascots & Mnemonics GLP-1 Receptor Agonists and Diabetic

Emerging evidence suggests their neuroprotective effects in neurodegenerative disorders, particularly Alzheimers disease, as well as potential anti-tumor properties in various malignancies [7]

Patients with cardiovascular risk factors may therefore find a GLP-1RA more appropriate owing to the improvements in cardiometabolic parameters that have been observed with this drug class [10, 37, 46, 47]

M., Okemah J., and O'Neil P

The first identified incretin was a gastric inhibitory peptide (GIP) with the activity of inhibiting the secretion of gastric acid, which was isolated from porcine small intestines (12)

Moreover, we included three additional RCTs (two vs basal insulin [20, 21] and one vs placebo [19]), totalling a considerably larger number of participants ( n = 6609)

10.1016/j.apsb.2024.03.011 31 HernndezC.BogdanovP.CorralizaL.Garca-RamrezM.Sol-AdellC.ArranzJ